Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other: 2016-2025
Historic Receivables - Other for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Sep 2025 value amounting to $70.0 million.
- Viridian Therapeutics, Inc.\DE's Receivables - Other rose 499900.00% to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.0 million, marking a year-over-year increase of 499900.00%. This contributed to the annual value of $102,000 for FY2023, which is negligibly% changed negligibly from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Receivables - Other stood at $70.0 million for Q3 2025, which was up 499,900.00% from $14,000 recorded in Q3 2024.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Other peaked at $70.0 million during Q3 2025, and registered a low of $14,000 during Q3 2024.
- Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Receivables - Other value was $102,000 (recorded in 2024), while the average stood at $10.1 million.
- Its Receivables - Other has fluctuated over the past 5 years, first slumped by 86.27% in 2024, then soared by 499,900.00% in 2025.
- Viridian Therapeutics, Inc.\DE's Receivables - Other (Quarterly) stood at $451,000 in 2021, then crashed by 77.38% to $102,000 in 2022, then remained steady at $102,000 in 2023, then plummeted by 86.27% to $14,000 in 2024, then surged by 499,900.00% to $70.0 million in 2025.
- Its Receivables - Other stands at $70.0 million for Q3 2025, versus $14,000 for Q3 2024 and $102,000 for Q1 2024.